Editor’s Note: This roundup is intended to highlight some of the month’s most notable funding rounds and is not intended to be exhaustive.
Health technology companies made several major funding announcements in December. Here is a list of some of the largest funding rounds.
Curative secures $150 million in Series B financing
Curative, based in Austin, Texas, offers an employer-based health plan with $0 out-of-pocket costs, no copays, deductibles, or coinsurance. Members only need to complete one annual preventive health visit to get $0 out-of-pocket costs.
The Series B funding was led by TED President Chris Anderson’s Upside Vision Fund and included participation from Justin Mateen, founder of the JAM Fund. Additional investors include Galaxy Digital’s Mike Novogratz, Stanley Druckenmiller’s Duquesne Family Office, DCVC and Martin Varsavsky. The funding will help scale Curative’s business nationally, according to the announcement.
Angle Health raises $134 million in Series B financing
San Francisco-based Angle Health is a digital healthcare benefits provider for employers. Its AI-powered app offers care navigation services through its care team. Their customizable health plans include telemedicine, behavioral health, and other digital health solutions. The company can also help with payment processing and billing, and serves more than 3,000 employers in 44 states.
Angle Health’s Series B round was led by Portage and included participation from Blumberg Capital, Mighty Capital, PruVen Capital, SixThirty Ventures, TSVC, Wing VC, and Y Combinator. The round included a mix of debt and equity. In total, Angle Health has raised around $200 million.
Paradigm Health raises $78 million in Series B financing
Paradigm Health offers an AI-powered platform that aims to provide equitable access to clinical trials for patients. The platform automates patient matching to clinical trials and helps health systems recruit eligible patients for trials.
The financing was led by ARCH Venture Partners, with participation from DFJ Growth, F-Prime, General Catalyst, GV, Lux Capital, Mubadala Capital and the American Cancer Society’s BrightEdge Fund. The funding “will be used to accelerate Paradigm Health’s expansion as demand grows from global biopharmaceutical companies for more efficient trials and from health systems seeking to offer trials to patients closer to where they receive routine care,” according to the announcement.
Artera raises $65 million in financing
Artera, based in Santa Barbara, California, is a health technology company that leverages artificial intelligence to help providers communicate more easily with patients. Their platform uses automated text, voice, and web messaging to manage things like appointment scheduling, intake, and billing.
Funding included support from Lead Edge Capital, Jackson Square Ventures, Health Velocity Capital, Heritage Medical Systems and Summation Health Ventures. You will help Artera further grow its business and embrace agent AI in healthcare.
Photo: Abscent84, Getty Images